「no」の検索結果
164件：21～25件目を表示
-
Data And Statistics | About Senju | SENJU Pharmaceutical
Sales Revenue 2021.3 2022.3* 2023.3* 2024.3* 2025.3* Sales Revenue 40.7 40.8 46.4 48.9 48.9 Operating Profit 5.4 6.9 7.4 7.1 2.4 Ordinary Profit 8.0 9.1 8.7 9.1 2.9 Total Assets 75.8 83.9 88.2 98.4 10
https://www.senju.co.jp/english/about/sales.html -
お知らせ | 千寿製薬株式会社
https://www.senju.co.jp/english/news/javascipt: void(0); -
研究開発の取り組み | 千寿製薬株式会社
R & D activities Product Development Policy Research and Development System R & D Pipeline Clinical trial information Publications Meetings of the Minds Business Collaboration Inquiries licens
https://www.senju.co.jp/english/rd/ -
Meetings of the Minds | Research & Development | SENJU Pharmaceutica
le-Masked, Placebo-Controlled Phase 3 Pivotal Study – Yuichi Hori, MD, PhD; Tomoyuki Wada, PhD; Kazunori Omatsu, BSc the 59th Congress of the European Societies of Toxicology 開催日：2025年9月14日～2025年9月17日...
https://www.senju.co.jp/english/rd/society/ -
General Announcement: September 6, 2024 Senju Pharmaceutical Co., Ltd. Launch of Distribution of Software for Dry-eye Analysis Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr...
https://www.senju.co.jp/system/files/content_news/2024-09/ENG_20240906_0.pdf